Brain injury and growth inhibitory factor (GIF) - A Minireview

Neurochemical Research

Volumn 23, Issue 3, 1998, Pages 319-328

  Hozumi, I ^a   Inuzuka, T ^a   Tsuji, S ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Brain injury; Growth inhibitory factor; Metallothionein; Neurodegenerative disease; Reactive astrocyte

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; GROWTH INHIBITOR;

ALZHEIMER DISEASE; ASTROCYTE; BRAIN INJURY; BRAIN RADIATION; DEGENERATIVE DISEASE; GLIOSIS; HUMAN; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SENILE PLAQUE; STAB WOUND; TISSUE REPAIR;

AMINO ACID SEQUENCE; ANIMALS; BRAIN INJURIES; GROWTH INHIBITORS; HUMANS; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS;

EID: 0031935540     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022401315721     Document Type: Review

References (75)

1. Terry, R. D., Peck, A., De Teresa, R., Schechter, R., and Horoupian, D. S. 1981. Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Ann. Neurol. 10:184-192.
2. Appel, S. H. 1981. A unifying hypothesis for the cause of amyotrophic lateral sclerosis, Parkinsonism, and Alzheimer's disease. Ann. Neurol. 10:499-505.
3. Uchida, Y., Ihara, Y., and Tomonaga, M. 1988. Alzheimer's disease brain extract stimulates the survival of cerebral cortical neurons from neonatal rats. Biochem. Biophys. Res. Commun. 150:1263-1267.
4. Ihara, Y. 1988. Massive somatodendritic sprouting of cortical neurons in Alzheimer's disease. Brain Res. 459:138-144.
5. Uchida, Y., and Tomonaga, M. 1989. Neurotrophic action of Alzheimer's disease brain extract is due to the loss of inhibitory factors for survival and neurite formation of cerebral cortical neurons. Brain Res. 481:190-193.
6. Uchida, Y., Takio, K., Titani, K., Ihara, Y., and Tomonaga, M. 1991. The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein. Neuron 7:337-347.
7. Tsuji, S., Kobayahi, H., Uchida, Y., Ihara, Y., and Miyatake, T. 1992. Molecular cloning of human growth inhibitory factor cDNA and its down-regulation in Alzheimer's disease. The EMBO Journal, 13:4843-4850.
8. Palmiter, R. D., Findley, S. D., Whitemore, T. E., and Durnam, D. M. 1992. MT-III, a brain-specific member of the metallothionein gene family. Proc. Natl. Acad. Sci. USA, 89:6333-6337.
9. Masters, B. A., Quaife, C. J., Erickson, J. C., Kelly, J. K., Froelick, G. J., Zambrowicz, B. P., Brinster, R. L., and Palmiter, R. D. 1994. Methallothionein III is expressed in neurons that sequester zinc in synaptic vesicles. J. Neurosci., 14:5844-5857.
10. Anezaki, T., Ishiguro, H., Hozumi, I., Inuzuka, T., Hiraiwa, M., Kobayashi, H., Yuguchi, T., Wanaka, A., Uda, Y., Miyatake, T., Tohyama, M., and Tsuji, S. 1995. Expression of growth inhibitory factor (GIF) in normal and injured rat brains. Neurochem. Int. 27:89-94.
11. Yuguchi, T., Kohmura, E., Yamada, K., Sasaki, T., Yamashita, T., Otsuki, H., Wanaka, A., Tohyama, M., Tsuji, S., and Hayakawa, T. 1995. Changes in growth inhibitory factor mRNA expression following facial nerve transection, Mol. Brain Res., 28:181-185.
12. Uchida, Y., Shimizu, T., and Ihara, Y. 1994. Inhibition of β-amyloid-induced toxicity by GIF (in Japanese). Bulletin of the Japanese Society for Neurochemistry. 35 (3): 184-185.
13. Hozumi, I., Inuzuka, T., Hiraiwa, M., Uchida, Y., Anezaki, T., Ishiguro, H., Kobayashi, H., Uda, Y., Tadashi, M., and Tsuji, S. 1995. Changes of growth inhibitory factor after stab wounds in rat brain, Brain Res. 688:143-148.
14. Hozumi, I., Inuzuka, T., Ishiguro H., Hiraiwa, M., Uchida, Y., and Tsuji, S. 1996. Immunoreactivity of growth inhibitory factor in normal rat brain and after stab wounds - An immunocytochemical study using confocal laser scanning microscopy. Brain Res. 741:197-204.
15. Inuzuka, T., Hozumi, I., Tamura A., Hiraiwa, M., and Tsuji, S. 1996. Patterns of growth inhibitory factor (GIF) and glial fibrillary acidic protein relative level changes differ from left middle cerebral artery occlusion in rats. Brain Res. 709:151-153.
16. Akiyama, K., Sato, M., Takeda, N., Tanaka. 1997. Changes in growth inhibitory factor (GIF) and glial fibrillary acidic protein (GFAP) after irradiation on neonatal rat brains. Trans, 11th International Congress of Neurological Surgery. 1775-1780.
17. Kobayashi, H., Uchida, Y., Ihara, Y., Nakajima, K., Kohsaka S., Miyatake, T., and Tsuji, S. 1993. Molecular cloning of rat growth inhibitory factor cDNA and the expression in the central nervous system. Mol. Brain Res. 19:199-194.
18. Pountney, D. L., Fundel, S. M., Faller, P., Birchler N. E., Hunziker, P., and Vasak, M. 1994. Isolation, primary structures and metal binding properties of neuronal growth inhibitory factor (GIF) from bovine and equine brain. FEBS Letters. 345:193-197.
19. Quaife, C. J., Findley, S. D., Erickson, J. C., Froelick, G. J., Kelley, E. J., Zambrowicz, B. P., and Palmiter, R. D. 1994. Induction of a new metallothionein (MT-IV) occurs during differentiation of stratified squamous epithelia. Biochem. 33:7250-7259.
20. Tsuji, S., Kobayashi, H., Uchida, Y., Ihara, Y., and Miyatake, T. 1995. Molecular cloning of human growth inhibitory factor cDNA and its down-regulation in Alzheimer's disease. Page 677-683, in Hanin, I. et al. (eds.), Alzheimer's and Parkinson's Disease, Plenum Press, New York.
21. Naruse, S., Igarashi, S., Furuya, T., Kobayashi, H., Miyatake, T., and Tsuji, S. 1994. Structures of human and mouse growth inhibitory factor-encoding genes. Genes. 144:283-287
22. Rudge, J. S. 1993. Astrocyte-derived neurotrophic factors. Pages 267-305, in Murphy, S. (ed.), Astrocytes -pharmacology and function, Academic Press, San Diego.
23. Imagawa, M., Ishikawa, Y., Shimamoto, H., Osada, S., and Nishihara, T. 1995. CTG triplet repeat in mouse growth inhibitory factor/metallothionein III gene promoter represses the transcriptional activity of the heterologous promoters. J. Biol. Chem. 270:20898-20900.
24. Karin, M., 1985. Metallothioneins: proteins in search of function. Cell. 41:9-10.
25. Kagi, J. H. R., and Schaeffer, A. 1988. Biochemistry of metallothionein. Biochemistry. 27:8509-8515
26. Ebadi, M., Iversen, P. L., Hao, R., Cerutis, D. R., Rojas, C. P., Happe, H. K., Murrin, L. C., and Pfeiffer P. F. 1995. Expression and regulation of brain metallothionein. Neurochem. Int. 27:1-22.
27. Kramer, K. K., Liu, J., Choudhuri, S., and Klaassen, C. D. 1996. Induction of metallothionein mRNA and protein in murine astrocyte cultures. Toxicol. Appl. Pharmacol. 136:94-100.
28. Cousins, R. J. 1983. Metallothionein - aspects related to copper and zinc metabolism. J. Inner. Metab. Dis. 6 Suppl. 1:15-21.
29. Mizzen, C. A., Cartel, N. J., Yu, W. H., Fraser, P. E., and McLachlan, D. R. 1996. Sensitive detection of metallothioneins-1, - 2 and -3 in tissue homogenates by immunoblotting: a method for enhanced membrane transfer and retention. J. biochem. biophys. Methods. 32:77-83.
30. Young, J. K., Garvey, J. S., and Huang, P. C. 1991. Glial immunoreactivity for metallothionein in the rat brain. Glia. 4:602-610.
31. Yamada, M., Hayashi, S., Hozumi, I., Inuzuka, T., Tsuji S., and Takahashi. H. 1996. Subcellular localization of growth inhibitory factor in rat brain: light and electron microscopic immunohistochemical studies. Brain Res. 735:257-264.
32. Erickson, J. C., Sewell, A. K., Jensen, L. T., Winge, D. R., and Palmiter, R. D. 1994. Enhanced neurotrophic activity in Alzheimer's disease cortex is not associated with down-regulation of metallothionein-III (GIF). Brain Res. 649:297-304.
33. Palmter, D. P. 1995. Constitutive expression of metallothioneinIII (MT-III), but not MT-I, inhibits growth when cells become zinc deficient. Toxicol. Appl. Pharmacol. 135:139-145.
34. Uchida, Y., and Ihara, Y. 1995. The N-terminal portion of growth inhibitory factor is sufficient for biological activity. J. Biol. Chem. 270:3365-3369.
35. Sewell, A. K., Jensen L, T., Erickson, J. C., Palmiter R. D., and Winge, D. R. 1995. Bioactivity of metallothionein-3 correlates with its novel beta domain sequence rather than metal binding properties. Biochemistry 34:4740-4747.
36. Vallee, B. L. 1995. The function of metallothionein. Neurochem. Int. 27:22-33.
37. Abel, J., and de Ruiter, N. 1989. Inhibition of hydroxyl-radicalgenerated DNA degradation by metallothionein. Toxicol. Lett. 47:191-196.
38. Thornalley, P. J., and Vasak, M. 1985. Possible role for metallothionein against radiation-induced oxidative stress. Kinetics and mechanism of its reaction with superoxide and hydroxyl radicals. Biochim. Biophys. Acta. 827:36-44.
39. Uchida, Y. 1994. Growth-Inhibitory Factor, matallothionein-like protein, and neurodegenerative diseases. Biol. Signals. 3:211-215.
40. Duffy, P. E., Rapport, M., and Graf, L. 1980. Glial fibrillary acidic protein and Alzheimer-type senile dementia, Neurology, 30:778-782.
41. Mandybur, T. I., and Chuirazzi, C. C. 1990. Astrocytes and the plaques of Alzheimer's disease, Neurology, 40:635-639.
42. Delacourte, A. 1990. General and dramatic glial reaction in Alzheimer's brains Neurology, 40:33-37.
43. Pike, C. J., Cummings, B. J., and Cotman, C. W. 1995. Early association of reactive astrocytes with senile plaques in Alzheimer's disease. Exp. Neurol. 132:172-179.
44. Norton, W. T., Aquino, D. A., Hozumi, I., Chiu, F.-C., and Brosnan, C. F. 1992. Quantitative aspects of reactive gliosis: a review, Neurochem. Res. 17:877-885.
45. Hozumi, I., Chiu, F.-C., and Norton, W. T. 1990. Biochemical and immunocytochemical changes in glial fibrillary acidic protein after stab wounds. Brain Res. 524:64-71.
46. Hozumi, I., Aquino, D. A., and Norton, W. T. 1990. GFAP mRNA levels following stab wounds in rat brain. Brain Res. 534:291-294.
47. Yuguchi, T., Kohmura, E., Yamada, K., Sasaki, T., Yamashita, T., Otsuki, H., Kataoka, K., Tsuji, S., and Hayakawa, Y. 1995. Expression of growth inhibitory factor mRNA following injury in rat. 1995. J. Neurotrauma. 12:299-306.
48. Inuzuka, Tamura A., Sato, S., Kirino, T., Yanagisawa, K., Toyoshima, I., and Miyatake, T. 1990. Changes in the concentrations of cerebral proteins following occlusion of the middle cerebral artery in rats. Stroke. 21:917-922.
49. Holdorff, B. 1975. Radiation damage to the brain. Page 639-663. in Vinken, P.J., and Bruyn, G.W. (eds.), Handbook of Neurology, Vol. 23, Injuries of the brain and skull, Part I., North-Holland publishing company, Amsterdam.
50. Aquino, D. A., Chiu, F.-C., Brosnan, C. F., and Norton, W. T. 1988. Glial fibrillary acidic protein increases in the spinal cord of Lewis rats with acute experimental autoimmune encephalitis. J. Neurochem. 51:1085-1096.
51. Glenner, G. G., and Wong, C. W. 1984. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120:885-890.
52. Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., and Beyreuther, K. 1985. Amyloid plaque core protein in Alzheimer's disease and Down syndrome. Proc. Natl. Acad. Sci. 82:4245-4249.
53. Selkoe, D. J., Abraham, C. R., Podlisny, M. B., and Duffy, L. K. 1986. Isolation of low-molecular-weight proteins from amyloid plaque fibers in Alzheimer's disease. J. Neurochem. 46:1820-1834.
54. Selkoe, D. J. 1994. Alzheimer's disease: a central role for amyloid. J. Neuropath. Exp. Neurol. 53:438-447.
55. Games, D., Adams, D., Alessandrini, R., Barbour, R., Berthelette, P., Blackwell. C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., Guido, T., Hagopian, S., Johnson-Wood, K., Khan, K., Lee, M., Leibowitz, P., Lieberburg, I., Little, S., Masliah, E., Mc-Conlogue, L., Montoya-Zavala, M., Mucke, L., Paganini, L., Penniman, E., Power M., Schenk, D., Seubert, P., Snyder, B., Soriano, F., Tan, H., Vitale, J., Wadsworth, S., Wolozin, B., and Zhao, J. 1995. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precusor protein. Nature. 373:523-527.
56. Duguid, J. R., Bohmont, C. W., Liu, N., and Tourtellotte, W. W. 1989. Changes in brain gene expression shared by scrapie and Alzheimer's disease. Proc. Natl. Acad. Sci. 86:7276-7264.
57. Rothwell, N. J. 1996. The role of cytokines in neurodegeneration, Pages 145-177. in Rothwell, N.J. (ed.), Cytokines in the nervous system, Springer-Verlag, Heidelberg, Germany.
58. Bush, A. I., Pettingell, W. H., Multhaup, G., Paradis, Paradis, M. D., Vonsattel, J.-P., Gusella, J. F., Beyreuther, K., Masters, C. L., and Tanzi, R. E. 1994. Rapid induction of Alzheimer A β amyloid formation by zinc. Science 265:1464-1467.
59. Smith, M. A., Perry, G., Richey, P. L., Sayre, L. M., Anderson, V. E., Beal, M. F., and Kowall, N. 1996. Oxidative damage in Alzheimer's. Nature. 382:120-121.
60. Graves, A. B., White, E., Koepsell, T. D., Reifler, B. V., Belle, G., Larson, E. B., and Raskind, M. 1990. The association between head trauma and Alzheimer's disease. Am. J. Epidemiol. 131:491-501.
61. Roberts, G. W., Gentleman, S. M., Lynch, A., and Graham, D. I. 1991. βA4 amyloid protein deposition in brain after head trauma Lancet. 338:1422-1423.
62. Siddique, T., and Deng, H.-X. 1996. Genetics of amyotrophic lateral sclerosis. Hum. Mol. Genet. 5:1465-1470.
63. Yim, M. B., Kang, J-H. Yim, H-S., Kwak, H-S., Chock, P. B., and Stadtman, E. R. 1996. A gain-of-function of an amyotrophic lateral sclerosis-associated Cu, Zn-superoxide dismutase mutant: An enhancement of free radical formation due to a decrease in Km for hydrogen peroxide. Proc. Natl. Acad. Sci. 93:5709-5714.
64. Tamai, K. T., Gralla, E. B., Ellerby, L. M., Valentine, J. S. and Thiele, D. J. 1993. Yeast and mammalian metallothioneins functionally substitute for yeast copper-zinc superoxide dismutase. Proc. Natl. Acad. Sci. 990:8013-8017.
65. O'Brien, J. S., Carson, G. S., Seo, H.-C., Hiraiwa, M., Weiler, S., Tomich, J., BarrangerJ. A., Kahn, M., and Azuma, N., Kishimoto, Y. 1995. Identification of the neurotrophic factor sequence of prosaposin. FASEB J. 9:681-685.
66. Sano, A., Matsuda, S., Wen, T.-C., Kotani, Y., Kondoh, K., Ueno, S., Kakimoto, Y., Yoshimura, H., and Sakanaka, M. 1994. Protection by prosaposin against ischemia-induced learning disability and neuronal loss. Biochem. Biophys. Res. Commun. 204:994-1000.
67. Ignatius, M. J., Gebicke-Haerter P. J., Skene, J. H. P., Schilling, J. W., Weisgraber, K. H., Mahley, R. W., and Shooter E. M. 1986. Expression of apolipoprotein E during nerve degeneration and regeneration, Proc. Natl. Acad. Sci. 83:1125-1129.
68. Mahley, R. W. 1988. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology, Science 240:622-630.
69. Williams, L. R., Varon, S., Peterson, G. M., Wictorin, K., Fischer, W., Bjorklund, A., and Gage, F. H. 1986. Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection. Proc. Natl. Acad. Sci. 83:9231-9235.
70. Hefti, F., Dravid, A., and Hartikka, J. 1984. Chronic intraventricular injections of nerve growth factor elevate hippocampal choline acetyltransferase activity in adult rats with partial septo-hippocampal lesions. Brain Res. 293:305-311.
71. Shigeno, T., Mima, T., Takakura, K., Graham, D. I., Kato, G., Hashimoto, Y., and Furukawa, S. 1991. Ameriolation of delayed neuronal death in the hippocampus by nerve growth factor. J. Neurosci. 11:2914-2919.
72. Mattson, M. P., Murrain, M., Guthrie, P. B., and Kater, S. B. 1989. Fibroblast growth factor and glutamate: Opposing roles in the generation and degeneration of hippocampal neuroarchitecture. J. Neurosci. 9:3728-3740.
73. Cheng, B., and Mattson, M. P. NGF and bFGF protect rat hippocampal and human cortical neurons against hypoglycemia damage by stabilizing calcium homeostasis. Neuron, 7:1031-1041.
74. Cordell, E. G., Bednar, M. M., Howard, D. B., Sporn, M. B. 1993. Transforming growth factor-β1 reduces infarct size after experimental cerebral ischemia in a rabbit model. Stroke 24:558-562.
75. Recio-Pinto, E., and Ishii, D. N. 1984. Effects of insulin, insulin-like growth factor-II and nerve growth factor on neurite out-growth in cultured human neuroblastoma cells. Brain Res. 302:323-334.